These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28123598)

  • 41. Rapid generation of genetic diversity by multiplex CRISPR/Cas9 genome editing in rice.
    Shen L; Hua Y; Fu Y; Li J; Liu Q; Jiao X; Xin G; Wang J; Wang X; Yan C; Wang K
    Sci China Life Sci; 2017 May; 60(5):506-515. PubMed ID: 28349304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent Advances in Genome Editing Using CRISPR/Cas9.
    Ding Y; Li H; Chen LL; Xie K
    Front Plant Sci; 2016; 7():703. PubMed ID: 27252719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CRISPR/Cas9 Targeted Editing of Genes Associated With Fungal Susceptibility in
    Olivares F; Loyola R; Olmedo B; Miccono MLÁ; Aguirre C; Vergara R; Riquelme D; Madrid G; Plantat P; Mora R; Espinoza D; Prieto H
    Front Plant Sci; 2021; 12():791030. PubMed ID: 35003180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using CRISPR/Cas9 Technology for Manipulating Cell Death Regulators.
    Kueh AJ; Herold MJ
    Methods Mol Biol; 2016; 1419():253-64. PubMed ID: 27108444
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
    Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement of baculovirus as protein expression vector and as biopesticide by CRISPR/Cas9 editing.
    Pazmiño-Ibarra V; Mengual-Martí A; Targovnik AM; Herrero S
    Biotechnol Bioeng; 2019 Nov; 116(11):2823-2833. PubMed ID: 31403180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamics of Indel Profiles Induced by Various CRISPR/Cas9 Delivery Methods.
    Kosicki M; Rajan SS; Lorenzetti FC; Wandall HH; Narimatsu Y; Metzakopian E; Bennett EP
    Prog Mol Biol Transl Sci; 2017; 152():49-67. PubMed ID: 29150004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes.
    Ehrke-Schulz E; Schiwon M; Leitner T; Dávid S; Bergmann T; Liu J; Ehrhardt A
    Sci Rep; 2017 Dec; 7(1):17113. PubMed ID: 29215041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High efficient multisites genome editing in allotetraploid cotton (Gossypium hirsutum) using CRISPR/Cas9 system.
    Wang P; Zhang J; Sun L; Ma Y; Xu J; Liang S; Deng J; Tan J; Zhang Q; Tu L; Daniell H; Jin S; Zhang X
    Plant Biotechnol J; 2018 Jan; 16(1):137-150. PubMed ID: 28499063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CRISPR/Cas9-mediated efficient targeted mutagenesis in grape in the first generation.
    Wang X; Tu M; Wang D; Liu J; Li Y; Li Z; Wang Y; Wang X
    Plant Biotechnol J; 2018 Apr; 16(4):844-855. PubMed ID: 28905515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration.
    Farhang N; Ginley-Hidinger M; Berrett KC; Gertz J; Lawrence B; Bowles RD
    Hum Gene Ther; 2019 Sep; 30(9):1161-1175. PubMed ID: 31140325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficient Genome Editing Using CRISPR/Cas9 Technology in Chicory.
    Bernard G; Gagneul D; Alves Dos Santos H; Etienne A; Hilbert JL; Rambaud C
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9.
    Abrahimi P; Chang WG; Kluger MS; Qyang Y; Tellides G; Saltzman WM; Pober JS
    Circ Res; 2015 Jul; 117(2):121-8. PubMed ID: 25940550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system.
    Li Y; Zhang W; Zhao J; Li S; Shan L; Zhu J; Li Y; Zhu H; Mao Q; Xia H
    Cytotechnology; 2018 Dec; 70(6):1595-1605. PubMed ID: 30173403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biosynthetic Nanobubble-Mediated CRISPR/Cas9 Gene Editing of Cdh2 Inhibits Breast Cancer Metastasis.
    Gao R; Luo Q; Li Y; Song L; Cai JS; Xiong Y; Yan F; Liu J
    Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
    Alagoz Y; Gurkok T; Zhang B; Unver T
    Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishment of an miR-137-knockout cell model using CRISPR/Cas9 genome editing.
    Chen W; Li Q; Du J; Li X; Jiang S; He Y
    Oncol Lett; 2018 Sep; 16(3):4027-4032. PubMed ID: 30128024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.